The 5th Annual OncoAlert Colloquium
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
PURPOSESWOG S1815 was a randomized, open label phase III trial, evaluating gemcitabine, nab-paclitaxel, and cisplatin (GAP) versus gemcitabine and cisplatin (GC) in patients with newly…
Can’t sign in? Forgot your password? If the address matches an existing account you will receive an email wit h instructions to reset your password.…
The increase in demand for mental health services is driven by an increase in poor mental health, but it’s also driven by greater understanding of…
New findings are allowing oncology nurses to offer their patients more personalized management strategies for their cancer- or treatment-related symptoms. Symptom clusters in patients with…
Moderadores:Dr. Raúl Córdoba Mascuñano. Hospital Universitario Fundación Jiménez DÃaz, MadridDra. Ana MarÃn-Niebla. Hospital Universitario Vall d´Hebron, Bar…
AI presents some exciting opportunities for the NHS, but leaders need to drive the technology and not the other way round, reports Chris Stokel-Walker Artificial…
Confronting poor behaviour from someone you work with can seem difficult but there are ways to respond, Abi Rimmer hears Rakesh Patel, professor of medical…
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!
The Year in Review in Oncology 2024 brought to you by some of the Worlds TOP experts!